In the United States, antibiotic resistance causes illness in 2 million people and 23,000 deaths.
One of the purposes of the ARLN is the identification of resistance mechanisms. Clinical samples are not routinely tested because it is not needed for patient-level decisions and insurance companies will not reimburse providers.
This article about a United States health organization is a stub. You can help Misplaced Pages by expanding it.